Are estrogen-related drugs new alternatives for the management of osteoarthritis?
Open Access
- 28 June 2016
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 18 (1) , 1-9
Abstract
Osteoarthritis (OA) is a chronic degenerative disease involving multiple physiopathological mechanisms. The increased prevalence of OA after menopause and the presence of estrogen receptors in joint tissues suggest that estrogen could help prevent development of OA. This review summarizes OA research with a focus on the effects of estrogen and selective estrogen receptor modulators (SERMs). Preclinical studies and clinical trials of estrogen therapy have reported inconsistent results. However, almost all studies assessing SERM treatment have obtained more consistent and favorable effects in OA with a relatively safety and tolerability profiles. At present, some SERMs including raloxifene and bazedoxifene have been approved for the treatment of osteoporosis. In summary, estrogen-related agents may exert both a direct effect on subchondral bone and direct and/or indirect effects upon the surrounding tissues, including the articular cartilage, synovium, and muscle, to name a few. Estrogen and SERMs may be particularly favorable for postmenopausal patients with early-stage OA or osteoporotic OA, a phenotype defined by reduced bone mineral density related to high remodeling in subchondral bone. At present, no single drug exists that can prevent OA progression. Although estrogen-related drugs provide insight into the continued work in the field of OA drug administration, further research is required before SERMs can become therapeutic alternatives for OA treatment.Keywords
Funding Information
- National Natural Science Foundation of China (31171136)
- Hebei Province Nature Science Foundation (H2013209257)
This publication has 77 references indexed in Scilit:
- Estrogen Aggravates Iodoacetate-induced Temporomandibular Joint OsteoarthritisJournal of Dental Research, 2013
- The Tissue Selective Estrogen Complex: A Promising New Menopausal TherapyPharmaceuticals, 2012
- Targeting Bone Alleviates Osteoarthritis in Osteopenic Mice and Modulates Cartilage CatabolismPLOS ONE, 2012
- Effect of Combined Sex Hormone Replacement on Bone/Cartilage Turnover in a Murine Model of OsteoarthritisClinics in Orthopedic Surgery, 2012
- 17β‐Oestradiol inhibits doxorubicin‐induced apoptosis via block of the volume‐sensitive Cl‐current in rabbit articular chondrocytesBritish Journal of Pharmacology, 2011
- Immunohistochemical Analysis of the Effects of Estrogen on Intraarticular Neurogenic Inflammation in a Rat Anterior Cruciate Ligament Transection Model of OsteoarthritisConnective Tissue Research, 2011
- Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritisArthritis Research & Therapy, 2010
- Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosisArthritis Research & Therapy, 2010
- Designing the ideal selective estrogen receptor modulator-an achievable goal?Menopause, 2009
- Osteoarthritis associated with estrogen deficiencyArthritis Research & Therapy, 2009